236 related articles for article (PubMed ID: 16805747)
1. Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy?
Gursoy A; Ozduman Cin M; Kamel N; Gullu S
Int J Clin Pract; 2006 Jun; 60(6):655-9. PubMed ID: 16805747
[TBL] [Abstract][Full Text] [Related]
2. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
Saravanan P; Siddique H; Simmons DJ; Greenwood R; Dayan CM
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):261-7. PubMed ID: 17479444
[TBL] [Abstract][Full Text] [Related]
4. Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.
Cakal E; Turgut AT; Demirbas B; Ozkaya M; Cakal B; Serter R; Aral Y
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):294-300. PubMed ID: 19085705
[TBL] [Abstract][Full Text] [Related]
5. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
[TBL] [Abstract][Full Text] [Related]
6. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
7. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
[TBL] [Abstract][Full Text] [Related]
8. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
Wadwekar D; Kabadi UM
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
[TBL] [Abstract][Full Text] [Related]
10. Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism.
Kebapcilar L; Akinci B; Bayraktar F; Comlekci A; Solak A; Demir T; Yener S; Küme T; Yesil S
Med Princ Pract; 2007; 16(6):432-6. PubMed ID: 17917442
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function and cholesterol level: paradoxical findings in large groups of population with high cholesterol food intake.
Langer P; Kocan A; Tajtakova M; Petrik J; Koska J; Hucková M; Hanzen E; Ksinantova L; Radikova Z; Imrich R; Trnovec T; Blazicek P; Sebokova E; Klimes I
Endocr Regul; 2003 Sep; 37(3):175-80. PubMed ID: 14986723
[TBL] [Abstract][Full Text] [Related]
12. Effect of L-thyroxine treatment on left ventricular function in subclinical hypothyroidism.
Franzoni F; Galetta F; Fallahi P; Tocchini L; Merico G; Braccini L; Rossi M; Carpi A; Antonelli A; Santoro G
Biomed Pharmacother; 2006 Sep; 60(8):431-6. PubMed ID: 16935462
[TBL] [Abstract][Full Text] [Related]
13. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR
Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
[TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism.
Hueston WJ; King DE; Geesey ME
Clin Endocrinol (Oxf); 2005 Nov; 63(5):582-7. PubMed ID: 16268812
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery.
Nagasaki T; Inaba M; Shirakawa K; Hiura Y; Tahara H; Kumeda Y; Ishikawa T; Ishimura E; Nishizawa Y
Biomed Pharmacother; 2007; 61(2-3):167-72. PubMed ID: 17383146
[TBL] [Abstract][Full Text] [Related]
17. Variability of L-thyroxine replacement dose in elderly patients with primary hypothyroidism.
Kabadi UM
J Fam Pract; 1987 May; 24(5):473-7. PubMed ID: 3106558
[TBL] [Abstract][Full Text] [Related]
18. [Subclinical hypothyroidism].
Krysiak R; Marek B; Okopień B
Wiad Lek; 2008; 61(4-6):139-45. PubMed ID: 18939365
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the parameters used in monitoring hypothyroid patients treated with L-thyroxine].
Custro N; Scafidi V; Indovina I
Minerva Med; 1986 Dec; 77(47-48):2227-33. PubMed ID: 3101002
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients.
Cakal B; Cakal E; Demirbaş B; Ozkaya M; Karaahmetoğlu S; Serter R; Aral Y
J Korean Med Sci; 2007 Jun; 22(3):431-5. PubMed ID: 17596649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
